Head-to-head dispatch
ARSYNL Rx vs Enhance MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
ARSYNL Rx is a veteran-founded multi-service telehealth platform offering compounded GLP-1 weight-loss treatment — compounded semaglutide and tirzepatide, including a needle-free tirzepatide hypospray —…
Marked down on: Pricing is not shown until you select a product (product pages sit behind a bot-verification gate)
Desk Score
The clearest tiered compounded pricing in the ranking — separate lines for sema, tirzepatide, a microdose tier, and a sema+tirz combo — with lab testing built in.
Marked down on: Compounded only — not FDA-approved
Enhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 63/100 (C) for ARSYNL Rx. ARSYNL Rx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
ARSYNL Rx
63/100
C
Enhance MD
85/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | ARSYNL Rx | Enhance MD |
|---|---|---|
| Semaglutide | $233/mo (compounded) | $249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay |
| Tirzepatide | $366/mo (compounded) | $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay |
| Coverage | Coverage not published | Not publicly listed |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want compounded semaglutide & tirzepatide (incl. a tirzepatide hypospray) from a veteran-founded telehealth. | Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes. |
| Desk Score | 63/100C | 85/100B |
The verdict
Desk pick — Enhance MDEnhance MD takes this head-to-head with the higher Desk Score, 85/100 (B) against 63/100 (C) for ARSYNL Rx. ARSYNL Rx still holds its ground where its strengths line up with yours.
Choose ARSYNL Rx if…
Readers who want compounded semaglutide & tirzepatide (incl. a tirzepatide hypospray) from a veteran-founded telehealth.
$233/mo (compounded) sema · $366/mo (compounded) tirz · Coverage not published
Choose Enhance MD if…
Patients who want fully itemized compounded options and ongoing metabolic oversight, and don't need brand-name or oral routes.
$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay sema · $329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay tirz · Not publicly listed
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: ARSYNL Rx · Enhance MD.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- ARSYNL Rx vs CoreAge Rx
- Enhance MD vs Vaylen
- ARSYNL Rx vs Strut Health
- Enhance MD vs Ondra Health
- ARSYNL Rx vs Invigor Medical
- Enhance MD vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.